Recombinant vaccines in 2022: a perspective from the cell factory

Overview of attention for article published in Microbial Cell Factories, October 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 92 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 8 X posts from 7 X users, with an upper bound of 3,937 followers.

https://t.co/oO5OKYVEgx

18 Dec 2023

Reply Repost Favourite

#glycotime The diversity of recombinant antimicrobial vaccines and vaccine prototypes is revised here considering the cell factory types, through relevant examples of prototypes under development as well as already approved products! https://t.co/XKoy0TG

23 Nov 2022

Reply Repost Favourite

RT @IBB_UAB: 📄Nou article recentment publicat pel grup @NBT_IBB_UAB, a la revista @BioMedCentral "Recombinant vaccines in 2022: a perspec…

20 Oct 2022

Reply Repost Favourite

📄Nou article recentment publicat pel grup @NBT_IBB_UAB, a la revista @BioMedCentral "Recombinant vaccines in 2022: a perspective from the cell factory" #IBBpapers https://t.co/SZTRfcpAj7

20 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.